Atorvastatin decreases serum levels of advanced glycation end products (AGEs) in patients with type 2 diabetes.

PubWeight™: 0.87‹?›

🔗 View Article (PMID 17191111)

Published in Clin Exp Med on December 01, 2006

Authors

Y Jinnouchi, S Yamagishi, M Takeuchi, S Ishida, Y Jinnouchi, J Jinnouchi, T Imaizumi

Articles citing this

Atorvastatin decreases serum levels of advanced glycation endproducts (AGEs) in nonalcoholic steatohepatitis (NASH) patients with dyslipidemia: clinical usefulness of AGEs as a biomarker for the attenuation of NASH. J Gastroenterol (2010) 2.36

Statins stimulate the production of a soluble form of the receptor for advanced glycation end products. J Lipid Res (2013) 0.91

Atorvastatin exerts its anti-atherosclerotic effects by targeting the receptor for advanced glycation end products. Biochim Biophys Acta (2011) 0.83

Atorvastatin reduces proteinuria in non-diabetic chronic kidney disease patients partly via lowering serum levels of advanced glycation end products (AGEs). Oxid Med Cell Longev (2010) 0.82

Glyceraldehyde-derived pyridinium (GLAP) evokes oxidative stress and inflammatory and thrombogenic reactions in endothelial cells via the interaction with RAGE. Cardiovasc Diabetol (2015) 0.81

Prevention of arterial stiffening by using low-dose atorvastatin in diabetes is associated with decreased malondialdehyde. PLoS One (2014) 0.81

Relationship of Advanced Glycation End Products With Cardiovascular Disease in Menopausal Women. Reprod Sci (2014) 0.79

An alpha-glucosidase inhibitor, acarbose treatment decreases serum levels of glyceraldehyde-derived advanced glycation end products (AGEs) in patients with type 2 diabetes. Clin Exp Med (2009) 0.79

Role of receptor for advanced glycation end products (RAGE) in liver disease. Eur J Med Res (2015) 0.78

Advanced Glycation End Products: A Molecular Target for Vascular Complications in Diabetes. Mol Med (2015) 0.77

Involvement of TAGE-RAGE System in the Pathogenesis of Diabetic Retinopathy. J Ophthalmol (2010) 0.76

Serum Levels of Toxic AGEs (TAGE) May Be a Promising Novel Biomarker for the Onset/Progression of Lifestyle-Related Diseases. Diagnostics (Basel) (2016) 0.75

Is vitamin D deficiency related to accumulation of advanced glycation end products, markers of inflammation, and oxidative stress in diabetic subjects? Biomed Res Int (2015) 0.75

Articles by these authors

The complete genome sequence of the gram-positive bacterium Bacillus subtilis. Nature (1997) 33.47

Essential Bacillus subtilis genes. Proc Natl Acad Sci U S A (2003) 14.01

Predicting the clinical status of human breast cancer by using gene expression profiles. Proc Natl Acad Sci U S A (2001) 13.30

Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature (2000) 12.33

TRAF6 is a signal transducer for interleukin-1. Nature (1996) 7.38

The purification and properties of penicillin beta-lactamases mediated by transmissible R factors in Escherichia coli. J Biochem (1969) 5.35

Pirfenidone in idiopathic pulmonary fibrosis. Eur Respir J (2009) 4.63

SCE-963, a new broad-spectrum cephalosporin: in vitro and in vivo antibacterial activities. Antimicrob Agents Chemother (1978) 4.06

Mobilization of endothelial progenitor cells in patients with acute myocardial infarction. Circulation (2001) 4.01

Binding of neuroligins to PSD-95. Science (1997) 3.88

Demonstration of globin messenger sequences in giant nuclear precursors of messenger RNA of avian erythroblasts. Proc Natl Acad Sci U S A (1973) 3.88

Fission yeast cut3 and cut14, members of a ubiquitous protein family, are required for chromosome condensation and segregation in mitosis. EMBO J (1994) 3.83

The JAK-binding protein JAB inhibits Janus tyrosine kinase activity through binding in the activation loop. EMBO J (1999) 3.77

Implantation of bone marrow mononuclear cells into ischemic myocardium enhances collateral perfusion and regional function via side supply of angioblasts, angiogenic ligands, and cytokines. Circulation (2001) 3.50

E2F3 activity is regulated during the cell cycle and is required for the induction of S phase. Genes Dev (1998) 3.48

Variant of penicillinase mediated by an R factor in Escherichia coli. J Bacteriol (1970) 3.33

Muscular dystrophy and neuronal migration disorder caused by mutations in a glycosyltransferase, POMGnT1. Dev Cell (2001) 3.29

Drug resistance of enteric bacteria. XIV. Comparison of beta-lactamases in gram-negative rod bacteria resistant to alpha-aminobenzylpenicillin. Jpn J Microbiol (1968) 3.04

Single LDL apheresis improves endothelium-dependent vasodilatation in hypercholesterolemic humans. Circulation (1997) 3.04

Cefmenoxime (SCE-1365), a novel broad-spectrum cephalosporin: in vitro and in vivo antibacterial activities. Antimicrob Agents Chemother (1981) 3.03

Transplanted cord blood-derived endothelial precursor cells augment postnatal neovascularization. J Clin Invest (2000) 2.96

Endogenous nitric oxide synthase inhibitor: a novel marker of atherosclerosis. Circulation (1999) 2.77

Purification of a mouse nuclear factor that binds to both the A and B cores of the polyomavirus enhancer. J Virol (1990) 2.69

Mechanism of action of globomycin. J Antibiot (Tokyo) (1978) 2.66

The tumor necrosis factor receptor 2 signal transducers TRAF2 and c-IAP1 are components of the tumor necrosis factor receptor 1 signaling complex. Proc Natl Acad Sci U S A (1996) 2.62

Biochemical properties of a cephalosporin beta-lactamase from Pseudomonas aeruginosa. Jpn J Microbiol (1973) 2.50

E2F4 and E2F5 play an essential role in pocket protein-mediated G1 control. Mol Cell (2000) 2.48

Progression rate of ALSFRS-R at time of diagnosis predicts survival time in ALS. Neurology (2006) 2.31

Hepatitis C virus particle detected by immunoelectron microscopic study. J Gen Virol (1994) 2.28

Role of nitric oxide in reactive hyperemia in human forearm vessels. Circulation (1994) 2.26

Identification of a novel E2F3 product suggests a mechanism for determining specificity of repression by Rb proteins. Mol Cell Biol (2000) 2.24

Platelet-activating factor acetylhydrolase deficiency. A missense mutation near the active site of an anti-inflammatory phospholipase. J Clin Invest (1996) 2.21

Mutations in the cardiac troponin I gene associated with hypertrophic cardiomyopathy. Nat Genet (1997) 2.20

Interlaboratory/intermethod differences in functional sensitivity of immunometric assays of thyrotropin (TSH) and impact on reliability of measurement of subnormal concentrations of TSH. Clin Chem (1995) 2.15

The receptor for advanced glycation end products is induced by the glycation products themselves and tumor necrosis factor-alpha through nuclear factor-kappa B, and by 17beta-estradiol through Sp-1 in human vascular endothelial cells. J Biol Chem (2000) 2.15

Time to recurrence after recovery from major depressive episodes and its predictors. Psychol Med (2003) 2.14

Cefoxitin resistance by a chromosomal cephalosporinase in Escherichia coli. J Antibiot (Tokyo) (1980) 2.09

Development and prevention of advanced diabetic nephropathy in RAGE-overexpressing mice. J Clin Invest (2001) 2.07

A myosin missense mutation, not a null allele, causes familial hypertrophic cardiomyopathy. Circulation (1995) 1.98

Carcinoid of the ampulla of Vater. Clinical characteristics and morphologic features. Cancer (1994) 1.97

p93dis1, which is required for sister chromatid separation, is a novel microtubule and spindle pole body-associating protein phosphorylated at the Cdc2 target sites. Genes Dev (1995) 1.96

14-3-3 proteins regulate intracellular localization of the bZIP transcriptional activator RSG. Plant Cell (2001) 1.94

A simple method for the quantitative extraction of dye extravasated into the skin. J Pharm Pharmacol (1971) 1.93

Serum thyroglobulin autoantibodies: prevalence, influence on serum thyroglobulin measurement, and prognostic significance in patients with differentiated thyroid carcinoma. J Clin Endocrinol Metab (1998) 1.93

A phytochrome from the fern Adiantum with features of the putative photoreceptor NPH1. Proc Natl Acad Sci U S A (1998) 1.93

Augmentation of postnatal neovascularization with autologous bone marrow transplantation. Circulation (2001) 1.92

Molecular-weight determination of animal-cell RNA by electrophoresis in formamide under fully denaturing conditions on exponential polyacrylamide gels. Eur J Biochem (1976) 1.92

Peripheral blood levels of matrix metalloproteases-2 and -9 are elevated in patients with acute coronary syndromes. J Am Coll Cardiol (1998) 1.91

Cell surface phenotypes and expression of viral antigens of various human cell lines carrying human T-cell leukemia virus. Int J Cancer (1984) 1.89

Physical and functional mapping of Tn2603, a transposon encoding ampicillin, streptomycin, sulfonamide, and mercury resistance. Mol Gen Genet (1981) 1.88

Loss of E2F4 activity leads to abnormal development of multiple cellular lineages. Mol Cell (2000) 1.86

A novel multiple PDZ domain-containing molecule interacting with N-methyl-D-aspartate receptors and neuronal cell adhesion proteins. J Biol Chem (1998) 1.82

Transposition of the oxacillin-hydrolyzing penicillinase gene. J Bacteriol (1981) 1.82

Iodometric assay method for beta-lactamase with various beta-lactam antibiotics as substrates. Antimicrob Agents Chemother (1978) 1.79

Relation of pancreatic duct hyperplasia to carcinoma. Cancer (1979) 1.78

Erythromycin and common cold in COPD. Chest (2001) 1.78

Generation of a highly pathogenic avian influenza A virus from an avirulent field isolate by passaging in chickens. J Virol (2001) 1.77

Repression of shoot growth, a bZIP transcriptional activator, regulates cell elongation by controlling the level of gibberellins. Plant Cell (2000) 1.77

Penicillinases of Klebsiella pneumoniae and their phylogenetic relationship to penicillinases mediated by R factors. J Bacteriol (1973) 1.74

Complete nucleotide sequence of a skin element excised by DNA rearrangement during sporulation in Bacillus subtilis. Microbiology (1995) 1.70

A method for measuring the outer membrane-permeability of beta-lactam antibiotics in gram-negative bacteria. J Antibiot (Tokyo) (1977) 1.69

Efficiency of recombination by Cre transient expression in embryonic stem cells: comparison of various promoters. J Biochem (1997) 1.68

Inducible oxacillin-hydrolyzing penicillinase in Aeromonas hydrophila isolated from fish. Antimicrob Agents Chemother (1976) 1.67

Comparison of the levels of hepatocyte growth factor and vascular endothelial growth factor in aqueous fluid and serum with grades of retinopathy in patients with diabetes mellitus. Br J Ophthalmol (1999) 1.66

Tissue-specific suppressor T cells involved in self-tolerance are activated extrathymically by self-antigens. Immunology (1994) 1.65

Inhibition of intimal hyperplasia after balloon injury by antibodies to intercellular adhesion molecule-1 and lymphocyte function-associated antigen-1. Circulation (1997) 1.63

N (epsilon)-(carboxymethyl)lysine protein adduct is a major immunological epitope in proteins modified with advanced glycation end products of the Maillard reaction. Biochemistry (1996) 1.63

Pancreaticobiliary maljunction: retrospective and nationwide survey in Japan. J Hepatobiliary Pancreat Surg (2003) 1.62

High dose of Garcinia cambogia is effective in suppressing fat accumulation in developing male Zucker obese rats, but highly toxic to the testis. Food Chem Toxicol (2005) 1.61

The bacterial outer-membrane permeability of beta-lactam antibiotics. J Antibiot (Tokyo) (1979) 1.59

Structure and organization of Marchantia polymorpha chloroplast genome. II. Gene organization of the large single copy region from rps'12 to atpB. J Mol Biol (1988) 1.59

Autotriggering caused by cardiogenic oscillation during flow-triggered mechanical ventilation. Crit Care Med (2000) 1.57

IkappaBalpha ubiquitination is catalyzed by an SCF-like complex containing Skp1, cullin-1, and two F-box/WD40-repeat proteins, betaTrCP1 and betaTrCP2. Biochem Biophys Res Commun (1999) 1.56

Current status and performance goals for serum thyrotropin (TSH) assays. Clin Chem (1996) 1.56

Possible participation of autocrine and paracrine vascular endothelial growth factors in hypoxia-induced proliferation of endothelial cells and pericytes. J Biol Chem (1995) 1.55

Antitumor activity of 7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxy-camptothec in, a novel water-soluble derivative of camptothecin, against murine tumors. Cancer Res (1987) 1.53

Alteration in energetics in patients with left ventricular dysfunction after myocardial infarction: increased oxygen cost of contractility. Circulation (1996) 1.53

Induction of various blood-brain barrier properties in non-neural endothelial cells by close apposition to co-cultured astrocytes. Glia (1997) 1.51

Proposal of six new species in the genus Aureobacterium and transfer of Flavobacterium esteraromaticum Omelianski to the genus Aureobacterium as Aureobacterium esteraromaticum comb. nov. Int J Syst Bacteriol (1993) 1.50

Epidermal growth factor receptor expression correlates with poor prognosis in non-small cell lung cancer patients with p53 overexpression. Oncol Rep (2000) 1.49

Structure and organization of Marchantia polymorpha chloroplast genome. I. Cloning and gene identification. J Mol Biol (1988) 1.49

MR imaging of perinatal brain damage: comparison of clinical outcome with initial and follow-up MR findings. AJNR Am J Neuroradiol (1999) 1.48

Caveolae in mesangial cells and caveolin expression in mesangial proliferative glomerulonephritis. Kidney Int (2001) 1.47

Inhibition of intestinal cholesterol absorption by ezetimibe is a novel therapeutic target for fatty liver. Med Hypotheses (2005) 1.46

Hemodialysis impairs endothelial function via oxidative stress: effects of vitamin E-coated dialyzer. Circulation (2000) 1.46

Morphology and electrophysiological properties of squid giant axons perfused intracellularly with protease solution. J Gen Physiol (1969) 1.44

Neurodegenerative influence of oxidative stress in the retina of a murine model of diabetes. Diabetologia (2010) 1.42

Exogenous prostacyclin does not sensitize arterial baroreceptors. Am J Physiol (1991) 1.40

Beta-lactamase formation and resistance of Proteus morganii to various penicillins and cephalosporins. Jpn J Microbiol (1974) 1.39

Dermatomyositis with splenic and renal infarctions during corticosteroid therapy. Intern Med (2000) 1.39

Mixed venous oxygen saturation as a guide to tissue oxygenation and prognosis in patients with acute myocardial infarction. Am Heart J (1991) 1.39

Obstructive jaundice as a recurrent symptom of small cell lung cancer. Am J Gastroenterol (1999) 1.39

The first case of insulin-dependent diabetes mellitus with prominent spurious hyperglucagonemia due to interference of immunoglobulin G in glucagon radioimmunoassay (OAL-123) system. Horm Res (1996) 1.39

Interleukin-18 activates NF-kappaB in murine T helper type 1 cells. Biochem Biophys Res Commun (1997) 1.37

Importance of OGTT for diagnosing diabetes mellitus based on prevalence and incidence of retinopathy. Diabetes Res Clin Pract (2000) 1.36

Comparison between 1-hour and 24-hour drain clamping using diluted epinephrine solution after total knee arthroplasty. J Arthroplasty (2001) 1.35

Decreased bone mass and increased bone turnover with valproate therapy in adults with epilepsy. Neurology (2001) 1.35

Identification of genes differentially expressed in canine vasospastic cerebral arteries after subarachnoid hemorrhage. J Cereb Blood Flow Metab (1999) 1.35

Circulating interleukin-6 levels in patients with bronchial asthma. Am J Respir Crit Care Med (1995) 1.34